EXAS+123.64%10.0%
GH+265.96%10.0%
GRAL+124.24%10.0%
ICAD0.00%10.0%
MASS+28.69%10.0%
NVCR+40.91%10.0%
PACB-5.80%10.0%
PSNL+206.92%10.0%
RDNT+26.62%10.0%
STLN—10.0%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '25: Cancer Diagnostics, Platforms & Care Constituents
908 Devices Inc.MASS | 10.0% | -0.47% | 17.79% | -0.12% | 4.99% | 60.19% | 21.88% | 115.64% | 28.69% | $345.0M |
Exact Sciences CorporationEXAS | 10.0% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 123.64% | $20.03B |
GRAIL Inc.GRAL | 10.0% | 2.04% | 9.35% | 7.59% | 8.20% | -13.33% | 39.36% | 183.78% | 124.24% | $3.18B |
Guardant Health, Inc.GH | 10.0% | 2.12% | 10.76% | -3.34% | 0.73% | 59.76% | 73.78% | 275.21% | 265.96% | $21.90B |
iCAD, Inc.ICAD | 10.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $56.6M |
Novocure LtdNVCR | 10.0% | -1.35% | -9.07% | -7.33% | 8.15% | 24.13% | 17.41% | -10.54% | 40.91% | $1.86B |
Pacific Biosciences of California, Inc.PACB | 10.0% | -9.72% | -4.41% | -21.69% | -7.14% | -30.48% | -22.62% | 2.36% | -5.80% | $403.8M |
Personalis, Inc.PSNL | 10.0% | 0.00% | 14.77% | -5.72% | 6.79% | 69.85% | 49.23% | 279.78% | 206.92% | $1.44B |
RadNet, Inc.RDNT | 10.0% | -3.12% | 8.92% | -2.70% | 5.14% | -6.01% | -3.94% | 27.71% | 26.62% | $5.27B |
The Oncology Institute, Inc.STLN | 10.0% | — | — | 0.00% | — | — | — | — | — | $502.9M |
| Theme return | — | -1.17% | 5.35% | -2.02% | 3.05% | 23.77% | 20.98% | 113.15% | 82.42% | — |
| Average | 10.0% | -1.17% | 5.35% | -3.33% | 2.98% | 18.60% | 19.62% | 112.15% | 90.13% | $5.50B |
| Median | 10.0% | 0.00% | 8.92% | -1.41% | 4.99% | 3.30% | 17.41% | 115.64% | 40.91% | $1.65B |
| Std Dev | 0.0% | 3.38% | 8.58% | 7.23% | 4.74% | 34.47% | 28.41% | 109.13% | 90.92% | $7.89B |
| Min | 10.0% | -9.72% | -9.07% | -21.69% | -7.14% | -30.48% | -22.62% | -10.54% | -5.80% | $56.6M |
| Max | 10.0% | 2.12% | 17.79% | 7.59% | 8.20% | 69.85% | 73.78% | 279.78% | 265.96% | $21.90B |
| % Positive Tickers | 22.22% | 55.56% | 10.00% | 66.67% | 55.56% | 66.67% | 77.78% | 77.78% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '25: Cancer Diagnostics, Platforms & Care tracks 10 publicly listed stocks in this theme: EXAS, GH, GRAL, ICAD, MASS, NVCR, PACB, PSNL, RDNT, STLN. See the constituent table for details.